The case for reactive mass oral cholera vaccinations

PLoS Neglected Tropical Diseases

Volumn 5, Issue 1, 2011, Pages

  Reyburn, Rita ^a   Deen, Jacqueline L ^a   Grais, Rebecca F ^b   Bhattacharya, Sujit K ^c   Sur, Dipika ^c   Lopez, Anna L ^a   Jiddawi, Mohamed S ^d   Clemens, John D ^a   von Seidlein, Lorenz ^e  

^a International Vaccine Institute   (South Korea)

^b EPICENTRE   (France)

^c NICED   (India)

^d Ministry of Health Zanzibar   (Tanzania)

^e MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE;

ARTICLE; CAUSE OF DEATH; CHOLERA; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; INDIA; MASS IMMUNIZATION; PERIODICITY; TANZANIA; THERAPY DELAY; ZIMBABWE; ADOLESCENT; ADULT; AGED; CHILD; COMPUTER SIMULATION; FEMALE; IMMUNOLOGY; INFANT; MALE; METHODOLOGY; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHOLERA; CHOLERA VACCINES; COMPUTER SIMULATION; DISEASE OUTBREAKS; FEMALE; HUMANS; INDIA; INFANT; INFANT, NEWBORN; MALE; MASS VACCINATION; MIDDLE AGED; MODELS, STATISTICAL; TANZANIA; YOUNG ADULT; ZIMBABWE;

EID: 79851487363     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000952     Document Type: Article

References (23)

1. WHO (2009) Meeting of the Strategic Advisory Group of Experts on immunization, October 2009 - conclusions and recommendations. Weekly epidemiological record 50: 526-528.
2. WHO (2008) Outbreak News Cholera, Zimbabwe. Weekly epidemiological record 83: 449-450.
3. Bhattacharya S, Black R, Bourgeois L, Clemens J, Cravioto A, et al. (2009) Public health. The cholera crisis in Africa. Science 324: 885.
4. WHO (2009) Outbreak News Cholera, Zimbabwe. Weekly epidemiological record 84: 517-532.
5. WHO (2009) Cholera, 2008. Weekly epidemiological record 84: 309-324.
6. Clemens JD, Sack DA, Harris JR, Chakraborty J, Khan MR, et al. (1986) Field trial of oral cholera vaccines in Bangladesh. Lancet 2: 124-127.
7. Clemens JD, Sack DA, Harris JR, Van Loon F, Chakraborty J, et al. (1990) Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet 335: 270-273.
8. Lucas ME, Deen JL, von Seidlein L, Wang XY, Ampuero J, et al. (2005) Effectiveness of mass oral cholera vaccination in Beira, Mozambique. The New England journal of medicine 352: 757-767.
9. Girard MP, Steele D, Chaignat CL, Kieny MP (2006) A review of vaccine research and development: human enteric infections. Vaccine 24: 2732-2750.
10. Sridhar S (2009) An affordable cholera vaccine: an important step forward. Lancet.
11. Sur D, Lopez AL, Kanungo S, Paisley A, Manna B, et al. (2009) Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet.
12. Sur D, Lopez AL, Kanungo S, Paisley A, Manna B, et al. (2009) Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet 374: 1694-1702.
13. Sur D, Deen JL, Manna B, Niyogi SK, Deb AK, et al. (2005) The burden of cholera in the slums of Kolkata, India: data from a prospective, community based study. Archives of disease in childhood 90: 1175-1181.
14. OCHA; (last accessed August 2009)http://ochaonline.un.org/CholeraSituation/tabid/5147/language/en-US/Default.aspx.
15. Jertborn M, Svennerholm AM, Holmgren J (1993) Evaluation of different immunization schedules for oral cholera B subunit-whole cell vaccine in Swedish volunteers. Vaccine 11: 1007-1012.
16. Naficy A, Rao MR, Paquet C, Antona D, Sorkin A, et al. (1998) Treatment and vaccination strategies to control cholera in sub-Saharan refugee settings: a cost-effectiveness analysis. JAMA 279: 521-525.
17. LaForce FM, Konde K, Viviani S, Preziosi MP (2007) The Meningitis Vaccine Project. Vaccine 25 (Suppl 1): A97-100.
18. WHO (2009) Yellow fever vaccine: a global partnership http://www.who.int/csr/disease/yellowfev/global_partnership/en/index.html.
19. Ali M, Emch M, von Seidlein L, Yunus M, Sack DA, et al. (2005) Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Lancet 366: 44-49.
20. Longini IM Jr, Nizam A, Ali M, Yunus M, Shenvi N, et al. (2007) Controlling endemic cholera with oral vaccines. PLoS Med 4: e336.
21. Anh DD, Canh do G, Lopez AL, Thiem VD, Long PT, et al. (2007) Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults. Vaccine 25: 1149-1155.
22. Mahalanabis D, Lopez AL, Sur D, Deen J, Manna B, et al. (2008) A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India. PLoS One 3: e2323.
23. (WHO/HQ) CDWGoE (2010) Public health risk assessment and interventions. Earthquake: Haiti Geneva WHO.